J&J Win Highlights FDA's Impact On Hip Implant Cases

Law360, New York (April 18, 2013, 7:52 PM EDT) -- After a costly loss in its first trial, Johnson & Johnson subsidiary DePuy Inc. this week managed to even its record in metal-on-metal implant cases, and attorneys say a crucial difference was the company's ability to tell jurors that the U.S. Food and Drug Administration had cleared the device.

A state court jury in Chicago on Tuesday handed down a verdict in favor of DePuy, rejecting the plaintiff's request for $5 million in compensatory damages for injuries allegedly caused by her ASR XL hip implant....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.